The discovery and development of novel broad-spectrum MβLs inhibitors are urgent to overcome antibiotic resistance mediated by MβLs. Herein, the synthesized 21 compounds exhibited potent inhibition to the clinically important MβLs (NDM-1, IMP-1 and ImiS) and effectively restored the antibacterial efficacy of cefazolin and imipenem against harboring MβLs. was first identified to be dual functional broad-spectrum MβLs inhibitor through assemblage of covalent and metal binding scaffold, which irreversibly inhibited B1, B2 MβLs via forming a Se-S covalent bond, and competitively inhibited B3 MβLs by coordinating the metals at active site. The designed compounds can serve as potent broad-spectrum MβLs inhibitors and combat MβLs-producing 'superbug' in combination with β-lactams.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4155/fmc-2019-0008 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!